TNF, tumor necrosis factor, produced by immuno competent cells, binds to TNF receptors (TNFR) and induces pro-inflammatory cytokine secretion (the NFkB pathway can be involved), increased cell migration to epidermis, activation of keratinocytes.
Infliximab is a monoclonal antibody. It binds to
TNF, and inhibits binding of TNF to cell surface TNF
receptors